Order Article Reprints

Watanabe D, Nogami A, Okada K, Akiyama H, Umezawa Y, Miura O. FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. Cancers. 2019; 11(12):1827. https://doi.org/10.3390/cancers11121827

Watanabe, Daisuke, Ayako Nogami, Keigo Okada, Hiroki Akiyama, Yoshihiro Umezawa, and Osamu Miura. 2019. "FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM" Cancers 11, no. 12: 1827. https://doi.org/10.3390/cancers11121827

Watanabe, D., Nogami, A., Okada, K., Akiyama, H., Umezawa, Y., & Miura, O. (2019). FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. Cancers, 11(12), 1827. https://doi.org/10.3390/cancers11121827